Hualan Biological Engineering Inc. (SHE:002007)
China
· Delayed Price · Currency is CNY 14.54
+0.07 (0.48%)
Apr 29, 2026, 2:15 PM CST
SHE:002007 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 26,443 | 27,649 | 30,815 | 40,471 | 41,285 | 53,162 | Upgrade
|
| Market Cap Growth | -6.89% | -10.27% | -23.86% | -1.97% | -22.34% | -31.01% | Upgrade
|
| Enterprise Value | 24,599 | 24,568 | 28,917 | 39,272 | 40,273 | 50,356 | Upgrade
|
| Last Close Price | 14.47 | 15.13 | 16.14 | 20.83 | 21.01 | 26.79 | Upgrade
|
| PE Ratio | 30.81 | 29.40 | 28.33 | 27.32 | 38.36 | 40.93 | Upgrade
|
| Forward PE | 22.85 | 15.93 | 19.37 | 23.05 | 28.47 | 27.36 | Upgrade
|
| PS Ratio | 5.89 | 6.02 | 7.04 | 7.58 | 9.14 | 11.98 | Upgrade
|
| PB Ratio | 1.94 | 2.07 | 2.23 | 3.02 | 3.38 | 5.87 | Upgrade
|
| P/TBV Ratio | 2.32 | 2.47 | 2.67 | 3.67 | 4.09 | 6.54 | Upgrade
|
| P/FCF Ratio | 39.10 | 40.62 | 38.33 | 68.31 | 73.28 | 85.59 | Upgrade
|
| P/OCF Ratio | 30.84 | 31.49 | 29.09 | 30.07 | 43.13 | 37.11 | Upgrade
|
| PEG Ratio | 2.21 | 5.16 | 5.16 | 5.16 | 5.16 | 5.16 | Upgrade
|
| EV/Sales Ratio | 5.48 | 5.35 | 6.60 | 7.35 | 8.92 | 11.35 | Upgrade
|
| EV/EBITDA Ratio | 18.75 | 17.51 | 20.09 | 18.98 | 26.92 | 28.25 | Upgrade
|
| EV/EBIT Ratio | 23.79 | 21.75 | 24.53 | 21.69 | 32.92 | 31.75 | Upgrade
|
| EV/FCF Ratio | 36.38 | 36.10 | 35.97 | 66.29 | 71.49 | 81.07 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.03 | 0.07 | 0.08 | 0.09 | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.32 | 0.63 | 0.49 | 0.74 | 0.56 | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.67 | 1.13 | 1.71 | 1.97 | 1.61 | Upgrade
|
| Net Debt / Equity Ratio | -0.28 | -0.29 | -0.32 | -0.25 | -0.21 | -0.26 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.87 | -2.81 | -3.12 | -1.60 | -1.74 | -1.32 | Upgrade
|
| Net Debt / FCF Ratio | -5.56 | -5.80 | -5.58 | -5.59 | -4.61 | -3.78 | Upgrade
|
| Asset Turnover | 0.28 | 0.29 | 0.27 | 0.35 | 0.34 | 0.41 | Upgrade
|
| Inventory Turnover | 0.84 | 0.93 | 0.96 | 1.11 | 1.21 | 1.21 | Upgrade
|
| Quick Ratio | 4.44 | 3.61 | 3.17 | 2.68 | 2.85 | 2.46 | Upgrade
|
| Current Ratio | 6.57 | 4.93 | 4.07 | 3.61 | 3.76 | 3.09 | Upgrade
|
| Return on Equity (ROE) | 6.61% | 7.34% | 8.48% | 13.75% | 11.73% | 16.94% | Upgrade
|
| Return on Assets (ROA) | 4.08% | 4.47% | 4.54% | 7.34% | 5.82% | 9.19% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.12% | 10.24% | 10.45% | 15.57% | 13.09% | 24.42% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.50% | 8.40% | 8.40% | 13.40% | 9.70% | 17.00% | Upgrade
|
| Earnings Yield | 3.24% | 3.40% | 3.53% | 3.66% | 2.61% | 2.44% | Upgrade
|
| FCF Yield | 2.56% | 2.46% | 2.61% | 1.46% | 1.36% | 1.17% | Upgrade
|
| Dividend Yield | 6.92% | 6.61% | 1.24% | 1.44% | 1.43% | 0.75% | Upgrade
|
| Payout Ratio | 147.37% | 144.78% | 43.00% | 38.04% | 37.12% | 43.43% | Upgrade
|
| Buyback Yield / Dilution | 0.13% | 0.16% | -0.23% | 0.19% | 0.17% | -0.59% | Upgrade
|
| Total Shareholder Return | 7.04% | 6.77% | 1.01% | 1.63% | 1.60% | 0.16% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.